There is no placebo-controlled trial showing Sermorelin produces a meaningful reduction in visceral adipose tissue measured by imaging
Karen Plymel, Functional Medicine Expert GLP-1 Agonists for Medical Weight Loss: Safety, Efficacy, and Cost Considerations In the ever-evolving landscape of weight loss treatments, GLP-1 agonists have garnered attention for their potential to help individuals manage obesity and related conditions
So I figured Id give GLP-1 medications a shot
For injury use, the cocktail-tied dose math doesnt work see GLOW/KLOW for Injuries for why and what to use instead
Some patients may find that staying on a maintenance dose or reducing to a lower dose remains the better choice
The pharmacology beneath the price Any legitimate GLP-1 program is only as good as the pharmacology underneath it: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide)